Q1 2022 13F Holders as of 3/31/2022
-
Type / Class
-
Equity / Ordinary shares
-
Shares outstanding
-
49.9M
-
Number of holders
-
57
-
Total 13F shares, excl. options
-
19.7M
-
Shares change
-
+2.03M
-
Total reported value, excl. options
-
$590M
-
Value change
-
+$57.7M
-
Number of buys
-
33
-
Number of sells
-
-13
-
Price
-
$29.90
Significant Holders of Immunocore Holdings plc - Ordinary shares (IMCR) as of Q1 2022
62 filings reported holding IMCR - Immunocore Holdings plc - Ordinary shares as of Q1 2022.
Immunocore Holdings plc - Ordinary shares (IMCR) has 57 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 19.7M shares
of 49.9M outstanding shares and own 39.52% of the company stock.
Largest 10 shareholders include Rock Springs Capital Management LP (2.55M shares), BAKER BROS. ADVISORS LP (2.52M shares), RTW INVESTMENTS, LP (1.86M shares), FMR LLC (1.63M shares), Avidity Partners Management LP (1.36M shares), WELLINGTON MANAGEMENT GROUP LLP (1.34M shares), GENERAL ATLANTIC, L.P. (950K shares), FIRST MANHATTAN CO (809K shares), Bill & Melinda Gates Foundation (577K shares), and Paradigm Biocapital Advisors LP (499K shares).
This table shows the top 57 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.